Welcome to our dedicated page for ARGAN SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. SEC filings document the company’s operating results, material events and governance as a NYSE-listed construction services issuer. Recent 8-K filings report quarterly and fiscal financial results, cash dividends, share repurchase program actions, and engineering, procurement and construction contract developments involving Gemma Power Systems and power-generation projects.
Proxy materials cover board elections, executive compensation, equity awards, shareholder voting matters and related governance disclosures. The filings also identify Argan’s common stock registration and formal event reporting for capital allocation and project-backlog developments.
ARGAN INC director Lisa Larroque Alexander sold common stock in an open-market trade. On April 29, 2026, the reporting person sold 350 shares of Argan’s common stock at an average price of $630.58 per share.
After this transaction, the director directly owned 350 shares of Argan common stock, according to the Form 4. The filing reports no derivative securities, so the activity relates only to non-derivative common stock holdings.
ARGAN INC director William F. Leimkuhler reported open-market sales of 5,800 shares of Argan common stock. On April 28, 2026, he sold 5,000 shares directly at an average price of $617.41 per share.
On the same date, the Emily K. Leimkuhler Trust and the Elizabeth K. Leimkuhler Trust, for which he serves as trustee, each sold 400 shares in open-market transactions, at reported prices of $621.14 and $618.61 per share. Following these sales, Leimkuhler holds 36,495 shares directly, and each trust holds 500 shares indirectly attributed to him as trustee.
ARGAN INC director Jeffrey John Ronald Jr. reported an open-market sale of the company’s common stock. On April 27, 2026, he sold 2,698 shares at an average price of $664.84 per share, leaving 2,000 shares held directly and 8,000 shares held indirectly through a John R. Jeffrey IRA.
AGX notice of proposed sale under Rule 144: an affiliate notified intended sales of Common Stock tied to prior private acquisition and an individual sale. The filing lists 3,000 shares related to Morgan Stanley Smith Barney LLC (acquired 05/16/2025) and a reported sale of 2,581 shares by Peter W. Getsinger on 04/02/2026 for $1,426,606.36. The filing also includes a figure of 13,946,000 shares with an associated date of 04/29/2026.
Argan Inc. submitted a Form 144 notice reporting proposed or recent secondary sales of common stock. The filing shows a reported sale by William Leimkuhler of 8,444 shares for $5,053,538 on 04/13/2026. The filing also lists securities tied to earlier transactions: 5,000 shares from a 07/20/2020 stock option exercise and two 400-share open-market purchase entries dated 10/07/2013 and 10/08/2013.
Argan, Inc. (AGX) reported a Form 144 notice indicating proposed insider sales. The filing lists 4,698 shares under "Securities To Be Sold" (dated 04/21/2026) and shows three reported sales during the prior three months: 5,000 (01/27/2026), 4,556 (03/31/2026), and 3,636 (04/21/2026).
The transactions are linked to option exercise/equity grant activity and identify Charles Schwab & Co. as the broker. The filing provides contact details for the selling party, John R. Jeffrey, Jr., and lists the exchange as NYSE.
Argan, Inc. ownership disclosure: First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation jointly report beneficial ownership of 821,295 shares of Common stock, representing 5.89% as of 03/31/2026, filed on a Schedule 13G.
The filing states shared voting power 791,353 and shared dispositive power 821,295; the registrants disclaim sole beneficial ownership and describe holdings held through unit investment trusts and advisory accounts.
ARGAN INC executive Charles Edwin Collins IV, CEO of Gemma, reported option exercises and share sales in April 2026. He exercised stock options to acquire a total of 13,568 shares of common stock at exercise prices ranging from $33.81 to $148.72 per share.
On April 20, 2026, he exercised an option for 2,500 shares at $39.47 per share and sold 2,500 shares at $610 per share. On April 21, 2026, he exercised additional options totaling 11,068 shares and sold 11,068 shares at an average price of $621.61 per share. Following these transactions, he directly holds 30,320 shares of ARGAN common stock.
ARGAN INC director Jeffrey John Ronald Jr. reported an option exercise and share sale. On April 21, 2026, he exercised a stock option for 5,000 shares of common stock at $37.13 per share using a net settle method, receiving 4,698 shares of common stock.
That same day, he sold 3,636 shares of common stock in open-market transactions at an average price of $615.40 per share. After these transactions, he held 4,698 shares directly and 8,000 shares indirectly through a John R. Jeffrey IRA.